Innovating Works
IMMUNISA: A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer KATHOLIEKE UNIVERSITEIT LEUVEN tramitó un H2020: H2020-SC1-2016-2017 Cervical cancer (CxCa) is caused by high risk types of the human papillomavirus (a.o. HPV16). Prophylactic HPV vaccination is not the standa...
2017-11-21 - 2022-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.